The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Macular Degeneration Treatment Market Research Report 2025
Synopsis
Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.
The global Macular Degeneration Treatment market was valued at US$ 5950 million in 2023 and is anticipated to reach US$ 7869.7 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Macular Degeneration Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macular Degeneration Treatment.
Report Scope
The Macular Degeneration Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Macular Degeneration Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Macular Degeneration Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health Companies
Allergan
Novartis
Pfizer
Bayer
Roche
Sanofi
Santen Pharmaceuticals
Regeneron Pharmaceuticals
Kanghong Pharma
Segment by Type
Lucentis
Eylea
Avastin
Others
Segment by Application
Hospitals
Eye Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macular Degeneration Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.
The global Macular Degeneration Treatment market was valued at US$ 5950 million in 2023 and is anticipated to reach US$ 7869.7 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Macular Degeneration Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macular Degeneration Treatment.
Report Scope
The Macular Degeneration Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Macular Degeneration Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Macular Degeneration Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health Companies
Allergan
Novartis
Pfizer
Bayer
Roche
Sanofi
Santen Pharmaceuticals
Regeneron Pharmaceuticals
Kanghong Pharma
Segment by Type
Lucentis
Eylea
Avastin
Others
Segment by Application
Hospitals
Eye Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macular Degeneration Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Macular Degeneration Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Macular Degeneration Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Macular Degeneration Treatment Market Perspective (2019-2030)
2.2 Macular Degeneration Treatment Growth Trends by Region
2.2.1 Global Macular Degeneration Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Macular Degeneration Treatment Historic Market Size by Region (2019-2024)
2.2.3 Macular Degeneration Treatment Forecasted Market Size by Region (2025-2030)
2.3 Macular Degeneration Treatment Market Dynamics
2.3.1 Macular Degeneration Treatment Industry Trends
2.3.2 Macular Degeneration Treatment Market Drivers
2.3.3 Macular Degeneration Treatment Market Challenges
2.3.4 Macular Degeneration Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Macular Degeneration Treatment Players by Revenue
3.1.1 Global Top Macular Degeneration Treatment Players by Revenue (2019-2024)
3.1.2 Global Macular Degeneration Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Macular Degeneration Treatment Revenue
3.4 Global Macular Degeneration Treatment Market Concentration Ratio
3.4.1 Global Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Macular Degeneration Treatment Revenue in 2023
3.5 Macular Degeneration Treatment Key Players Head office and Area Served
3.6 Key Players Macular Degeneration Treatment Product Solution and Service
3.7 Date of Enter into Macular Degeneration Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Macular Degeneration Treatment Breakdown Data by Type
4.1 Global Macular Degeneration Treatment Historic Market Size by Type (2019-2024)
4.2 Global Macular Degeneration Treatment Forecasted Market Size by Type (2025-2030)
5 Macular Degeneration Treatment Breakdown Data by Application
5.1 Global Macular Degeneration Treatment Historic Market Size by Application (2019-2024)
5.2 Global Macular Degeneration Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Macular Degeneration Treatment Market Size (2019-2030)
6.2 North America Macular Degeneration Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Macular Degeneration Treatment Market Size by Country (2019-2024)
6.4 North America Macular Degeneration Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Macular Degeneration Treatment Market Size (2019-2030)
7.2 Europe Macular Degeneration Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Macular Degeneration Treatment Market Size by Country (2019-2024)
7.4 Europe Macular Degeneration Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Macular Degeneration Treatment Market Size (2019-2030)
8.2 Asia-Pacific Macular Degeneration Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Macular Degeneration Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Macular Degeneration Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Macular Degeneration Treatment Market Size (2019-2030)
9.2 Latin America Macular Degeneration Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Macular Degeneration Treatment Market Size by Country (2019-2024)
9.4 Latin America Macular Degeneration Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Macular Degeneration Treatment Market Size (2019-2030)
10.2 Middle East & Africa Macular Degeneration Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Macular Degeneration Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Macular Degeneration Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health Companies
11.1.1 Bausch Health Companies Company Detail
11.1.2 Bausch Health Companies Business Overview
11.1.3 Bausch Health Companies Macular Degeneration Treatment Introduction
11.1.4 Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2019-2024)
11.1.5 Bausch Health Companies Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Macular Degeneration Treatment Introduction
11.2.4 Allergan Revenue in Macular Degeneration Treatment Business (2019-2024)
11.2.5 Allergan Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Macular Degeneration Treatment Introduction
11.3.4 Novartis Revenue in Macular Degeneration Treatment Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Macular Degeneration Treatment Introduction
11.4.4 Pfizer Revenue in Macular Degeneration Treatment Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Macular Degeneration Treatment Introduction
11.5.4 Bayer Revenue in Macular Degeneration Treatment Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Macular Degeneration Treatment Introduction
11.6.4 Roche Revenue in Macular Degeneration Treatment Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Macular Degeneration Treatment Introduction
11.7.4 Sanofi Revenue in Macular Degeneration Treatment Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 Santen Pharmaceuticals
11.8.1 Santen Pharmaceuticals Company Detail
11.8.2 Santen Pharmaceuticals Business Overview
11.8.3 Santen Pharmaceuticals Macular Degeneration Treatment Introduction
11.8.4 Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2019-2024)
11.8.5 Santen Pharmaceuticals Recent Development
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Company Detail
11.9.2 Regeneron Pharmaceuticals Business Overview
11.9.3 Regeneron Pharmaceuticals Macular Degeneration Treatment Introduction
11.9.4 Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2019-2024)
11.9.5 Regeneron Pharmaceuticals Recent Development
11.10 Kanghong Pharma
11.10.1 Kanghong Pharma Company Detail
11.10.2 Kanghong Pharma Business Overview
11.10.3 Kanghong Pharma Macular Degeneration Treatment Introduction
11.10.4 Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2019-2024)
11.10.5 Kanghong Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Macular Degeneration Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Lucentis
Table 3. Key Players of Eylea
Table 4. Key Players of Avastin
Table 5. Key Players of Others
Table 6. Global Macular Degeneration Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Macular Degeneration Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Macular Degeneration Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Macular Degeneration Treatment Market Share by Region (2019-2024)
Table 10. Global Macular Degeneration Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Macular Degeneration Treatment Market Share by Region (2025-2030)
Table 12. Macular Degeneration Treatment Market Trends
Table 13. Macular Degeneration Treatment Market Drivers
Table 14. Macular Degeneration Treatment Market Challenges
Table 15. Macular Degeneration Treatment Market Restraints
Table 16. Global Macular Degeneration Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Macular Degeneration Treatment Market Share by Players (2019-2024)
Table 18. Global Top Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Degeneration Treatment as of 2023)
Table 19. Ranking of Global Top Macular Degeneration Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Macular Degeneration Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Macular Degeneration Treatment Product Solution and Service
Table 23. Date of Enter into Macular Degeneration Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Macular Degeneration Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Macular Degeneration Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Macular Degeneration Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Macular Degeneration Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Macular Degeneration Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Macular Degeneration Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Macular Degeneration Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Macular Degeneration Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Macular Degeneration Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Macular Degeneration Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Macular Degeneration Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Macular Degeneration Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Macular Degeneration Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Macular Degeneration Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Macular Degeneration Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Macular Degeneration Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Macular Degeneration Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Macular Degeneration Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Macular Degeneration Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Macular Degeneration Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Bausch Health Companies Company Detail
Table 49. Bausch Health Companies Business Overview
Table 50. Bausch Health Companies Macular Degeneration Treatment Product
Table 51. Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
Table 52. Bausch Health Companies Recent Development
Table 53. Allergan Company Detail
Table 54. Allergan Business Overview
Table 55. Allergan Macular Degeneration Treatment Product
Table 56. Allergan Revenue in Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
Table 57. Allergan Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Macular Degeneration Treatment Product
Table 61. Novartis Revenue in Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Pfizer Company Detail
Table 64. Pfizer Business Overview
Table 65. Pfizer Macular Degeneration Treatment Product
Table 66. Pfizer Revenue in Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Bayer Company Detail
Table 69. Bayer Business Overview
Table 70. Bayer Macular Degeneration Treatment Product
Table 71. Bayer Revenue in Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
Table 72. Bayer Recent Development
Table 73. Roche Company Detail
Table 74. Roche Business Overview
Table 75. Roche Macular Degeneration Treatment Product
Table 76. Roche Revenue in Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Sanofi Company Detail
Table 79. Sanofi Business Overview
Table 80. Sanofi Macular Degeneration Treatment Product
Table 81. Sanofi Revenue in Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
Table 82. Sanofi Recent Development
Table 83. Santen Pharmaceuticals Company Detail
Table 84. Santen Pharmaceuticals Business Overview
Table 85. Santen Pharmaceuticals Macular Degeneration Treatment Product
Table 86. Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
Table 87. Santen Pharmaceuticals Recent Development
Table 88. Regeneron Pharmaceuticals Company Detail
Table 89. Regeneron Pharmaceuticals Business Overview
Table 90. Regeneron Pharmaceuticals Macular Degeneration Treatment Product
Table 91. Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
Table 92. Regeneron Pharmaceuticals Recent Development
Table 93. Kanghong Pharma Company Detail
Table 94. Kanghong Pharma Business Overview
Table 95. Kanghong Pharma Macular Degeneration Treatment Product
Table 96. Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2019-2024) & (US$ Million)
Table 97. Kanghong Pharma Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Macular Degeneration Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Macular Degeneration Treatment Market Share by Type: 2023 VS 2030
Figure 3. Lucentis Features
Figure 4. Eylea Features
Figure 5. Avastin Features
Figure 6. Others Features
Figure 7. Global Macular Degeneration Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Macular Degeneration Treatment Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Eye Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Macular Degeneration Treatment Report Years Considered
Figure 13. Global Macular Degeneration Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Macular Degeneration Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Macular Degeneration Treatment Market Share by Region: 2023 VS 2030
Figure 16. Global Macular Degeneration Treatment Market Share by Players in 2023
Figure 17. Global Top Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Degeneration Treatment as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Macular Degeneration Treatment Revenue in 2023
Figure 19. North America Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Macular Degeneration Treatment Market Share by Country (2019-2030)
Figure 21. United States Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Macular Degeneration Treatment Market Share by Country (2019-2030)
Figure 25. Germany Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Macular Degeneration Treatment Market Share by Region (2019-2030)
Figure 33. China Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Macular Degeneration Treatment Market Share by Country (2019-2030)
Figure 41. Mexico Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Macular Degeneration Treatment Market Share by Country (2019-2030)
Figure 45. Turkey Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Macular Degeneration Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Bausch Health Companies Revenue Growth Rate in Macular Degeneration Treatment Business (2019-2024)
Figure 48. Allergan Revenue Growth Rate in Macular Degeneration Treatment Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Macular Degeneration Treatment Business (2019-2024)
Figure 50. Pfizer Revenue Growth Rate in Macular Degeneration Treatment Business (2019-2024)
Figure 51. Bayer Revenue Growth Rate in Macular Degeneration Treatment Business (2019-2024)
Figure 52. Roche Revenue Growth Rate in Macular Degeneration Treatment Business (2019-2024)
Figure 53. Sanofi Revenue Growth Rate in Macular Degeneration Treatment Business (2019-2024)
Figure 54. Santen Pharmaceuticals Revenue Growth Rate in Macular Degeneration Treatment Business (2019-2024)
Figure 55. Regeneron Pharmaceuticals Revenue Growth Rate in Macular Degeneration Treatment Business (2019-2024)
Figure 56. Kanghong Pharma Revenue Growth Rate in Macular Degeneration Treatment Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
